Wyeth is a research-based, global pharmaceutical company that has established itself in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines and biotechnology. Its key divisions are Wyeth Pharmaceuticals, Wyeth Research, Wyeth Consumer Healthcare and Fort Dodge Animal Health.
The company states that it drives growth, pursues innovation and continues to look for ways to further improve its performance. A near-term challenge for Wyeth is the impact of generic competition for several of its major products.
Wyeth will continue with a robust pipeline and claims to have built a new product pipeline across a wide range of therapeutic areas that addresses unmet medical needs. The company's overall goal is to deliver to patients and doctors two new medicines each year. However, it believes its greatest challenge will be to create “breakthrough medicines” that serve the needs of patients in an increasingly competitive environment.
Wyeth with headquarters in Madison, New Jersey, employs almost 47,000 people in more than 140 countries and had annual sales of $23bn in 2008.
In October 2009, Pfizer completed its acquisition of Wyeth for $68bn (€52bn). For more on this please see Pfizer completes $68bn acquisition of US pharma rival Wyeth.
In January 2009, Pfizer agreed to buy Wyeth for around $68bn (€52bn).
ICIS Chemical Business magazine has unveiled the ICIS Top 100 Chemical Companies, with rankings based on 2008 sales.
A PDF of the ICIS Top 100 Chemical Companies is available for download on ICIS connect.
See the article and analysis of the ICIS Top 100 on ICIS news.
Key Personnel
Chairman, president and CEO: Bernard Poussot
Director: Robert Amen
Director: Michael Critelli
Director: Frances Fergusson
Director: Victor Ganzi
Director: Robert Langer
Director: John Mascotte
Director: Raymond McGuire
Director: Mary Lake Polan
Director: Gary Rogers
Director:
John Torell
(Updated July 2009)
Contacts
Wyeth
5 Giralda Farms
Madison
New Jersey 07940
US
Tel: +1 973 660 5000
Fax: +1 973 660 7026
Email: pr@wyeth.com
www.wyeth.com
Wyeth
Company Structure
Wyeth is a research-based, global pharmaceutical company that has established itself in the discovery, development, manufacturing and marketing of pharmaceuticals (prescription drugs and over-the-counter (OTC) medications), vaccines and biotechnology. Wyeth was previously known as American Home Products.
More about Wyeth Structure
Wyeth
Strategy & Financial Highlights
Wyeth will continue with a robust pipeline and claims to have built a new product pipeline across a wide range of therapeutic areas that addresses unmet medical needs. Wyeth's overall goal is to deliver to patients and doctors two new medicines each year. Key 2008 elements of the Wyeth strategy include advancement of 15 new compounds and three new vaccines to development, and the entry of 11 new medicines into first-in-human clinical trials. (Edited from annual report and company website). ICIS also provides you with key financial data listed in table form.
More about Wyeth Strategy & Financial Highlights
News:
Get news on Wyeth plus the latest chemical news, information, data, market movements and analysis
in one place with ICIS news
Search:
Find details on other chemical companies and suppliers with
ICIS search
Newsletters:
ICIS offers a range of FREE e-newsletters to ensure that you don't miss out on the latest development and key market intelligence in your industry. If you want the latest news sent to your inbox, sign up for ICIS e-newsletters today.
Plants and projects:
Find out more about current and planned chemical plants and projects by subscribing to our comprehensive database